• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Moleculin Biotech Inc.

Headquarters: Houston, TX, United States
Website: http://www.moleculin.com
Year Founded: 2015
Status: Public
Industry Sector: HealthTechnology
CEO: Walter V. Klemp, CPA
Number Of Employees: 17
Enterprise Value: $2,053,095
PE Ratio: -0.1
Exchange/Ticker 1: NASDAQ:MBRX
Exchange/Ticker 2: N/A
Latest Market Cap: $23,808,800

BioCentury | Jul 17, 2020
Product Development

Vaccine developments in China include IND acceptance for Fosun, Phase II start for Chongqing Zhifei

Read More
BioCentury | Apr 9, 2020
Product Development

April 8 COVID-19 roundup: National Academy of Sciences says COVID-19 could continue through summer; plus HHS, SAb-CSL, Vanda-UIC, Avacta-Cytiva and more

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
Read More
BioCentury | Aug 20, 2019
Clinical News

Aug. 20 Clinical Quick Takes: Oxurion misses in Phase II macular edema study; plus NuCana and Moleculin

Read More
BioCentury | Nov 9, 2017
Finance

The return of big

Highlights of public-private partnerships from 3Q17
Read More
BioCentury | Feb 10, 2017
Financial News

Moleculin completes follow-on

Read More
BioCentury | Jun 6, 2016
Financial News

Moleculin Biotech completes IPO

Read More
BioCentury | May 9, 2016
Financial News

Moleculin Biotech amends IPO

Read More
BioCentury | Feb 8, 2016
Financial News

Moleculin Biotech proposes IPO

Read More
Items per page:
1 - 8 of 8
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa